Thinking of joining a study?

Register your interest

NCT06489535 | NOT YET RECRUITING | Opioid Use Disorder


Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
Sponsor:

Boston Medical Center

Brief Summary:

This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy. Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs. The study objectives are to: * Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD. * Establish preliminary estimates of intervention efficacy. * Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials. Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program

Condition or disease

Opioid Use Disorder

Bloodstream Infection

Osteomyelitis

Endocarditis

Septic Arthritis

Epidural Abscess

Intervention/treatment

RETAIN

Unrelated videos

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 40 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN): A Pilot Randomized Controlled Study
Actual Study Start Date : 2024-11
Estimated Primary Completion Date : 2025-12
Estimated Study Completion Date : 2025-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Between 18 and 65 years of age
  • * Able to provide Informed Consent
  • * Admitted to Boston Medical Center on any inpatient unit for an active serious injection related infection (SIRI) such as endocarditis, osteomyelitis, bacteremia, septic arthritis, epidural abscess or other serious infection in which two weeks or more of antibiotics are recommended
Exclusion Criteria
  • * Not able to give informed consent
  • * Cognitive ability (defined through Research Assistant (RA) determination)
  • * Inability to complete assessments in English or Spanish (defined through RA determination).
  • * Exclusion for any reason under PI discretion
  • * Unable to provide names and contact information for at least two verifiable locator persons who will know where to find them in the future.
  • * In police custody or expecting incarceration

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

Location Details

NCT06489535


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, Massachusetts

Boston Medical Center

Boston, Massachusetts, United States, 02118

Loading...